A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab

Clinical trial NCT06782555 · RECRUITING

Trial details

NCT number: NCT06782555
Sponsor: ImmunoGenesis
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Prostate Cancer Metastatic Head and Neck Squamous Cell Carcinoma Metastatic Pancreatic Cancer

Start date: 2025-01-08
Primary completion: 2027-10-01
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.